urology.stanford.edu

2,862 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,862
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
9
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

urology.stanford.edu

  1. 1. MARK S. LITWIN, MD, MPH UCLA Department of Urology Tel (310) 206-8183 Box 951738 Fax (310) 206-5343 Los Angeles, CA 90095-1738 mlitwin@ucla.edu PROFESSIONAL 1993 – 1999 Assistant Professor of Urology, UCLA School of Medicine, Los Angeles, CA Assistant Professor of Health Services, UCLA School of Public Health, Los Angeles, CA 1999 – 2003 Associate Professor of Urology, UCLA School of Medicine, Los Angeles, CA Associate Professor of Health Services, UCLA School of Public Health, Los Angeles, CA 2003 – present Professor of Urology, UCLA School of Medicine, Los Angeles, CA Professor of Health Services, UCLA School of Public Health, Los Angeles, CA 1993 – present Health Policy Consultant, RAND Health, Santa Monica, CA Member, UCLA Jonsson Comprehensive Cancer Center Member, UCLA Center for Health Promotion and Disease Prevention EDUCATION 1981 A.B., Duke University, Durham, North Carolina, magna cum laude in Economics 1985 M.D., Emory University School of Medicine, Atlanta, Georgia 1987 Surgery Junior Residency, Harvard Program in Surgery, Brigham and Women's Hospital, Boston, MA 1991 Urology Residency, Harvard Program in Urology, Brigham and Women's Hospital, Boston, MA 1988-1989, Research Fellow with M. Judah Folkman, MD, The Children's Hospital, Boston, MA 1990-1991, Chief Resident in Urology, Harvard Program in Urology 1993 M.P.H. (Health Policy and Planning), University of California, Los Angeles 1991-1993 Robert Wood Johnson Clinical Scholar American Foundation for Urologic Disease, Health Policy Scholar Clinical Fellow, UCLA Division of Urology AWARDS AND HONORS 1983 Honorary Society for Collegiate Journalists 1984 Medical Association of Atlanta Essay Award, First place winner 1985 American Medical Association Jerry L. Pettis Award for excellence in scientific communication 1990 Resident Research Contest, Second place winner, American Urological Association, New England Section 1991 Basic Science Prize, Society of University Urology Residents, First place winner 1991 J. Hartwell Harrison Award in Urology, Brigham and Women's Hospital, Boston 1992 American Urological Association Socioeconomics Research Essay Contest, Second place winner 1993 American Urological Association Socioeconomics Research Essay Contest, Second place winner 1993 American Foundation for Urologic Disease New Investigator Award 1996 American Urological Association Socioeconomics Research Essay Contest, Third place winner 2001 American Urological Association Gold Cystoscope Award for outstanding contributions to urology 2007 Franklin D. Murphy Prize for research demonstrating innovation and leadership, Stein/Oppenheimer Foundation TEACHING AWARDS 1996 UCLA School of Medicine, Doctoring Program, Certificate of Distinction in Medical Education 1997 UCLA School of Medicine, Commencement Marshall 1997 UCLA School of Medicine Award for Excellence in Education
  2. 2. MARK S. LITWIN, MD, MPH Page 2 of 32 9/12/08 FUNDED PEER-REVIEWED RESEARCH GRANTS 1993 – 1995 Principal Investigator: Cost-efficacy in the treatment of patients with urinary tract infection, urinary stone disease, and erectile impotence $100,000, American Foundation for Urologic Disease 1993 – 1998 Principal Investigator: Health-related quality of life in men with metastatic prostate cancer $63,750, Integrated Therapeutics 1995 – 1996 Principal Investigator: Health-related quality of life in men treated for localized prostate cancer $20,000, University of California Cancer Research Coordinating Committee (CRCC) 1995 – 1996 Investigator: California Hospital Outcomes Project (P.I.: Gerald Kominski, PhD) $300,000, California Office of Statewide Health Planning and Development 1997 – 2002 Principal Investigator: Chronic Prostatitis Collaborative Clinical Research Studies $1,390,631, National Institutes of Health (1 R01 DK 53738) 1997 – 1998 Principal Investigator: Prostate Cancer Patient Outcomes and Choice of Providers $575,000, The Bing Fund (Los Angeles, CA) 1998 – 2000 Consultant: A study of black and white men with a family history of prostate cancer (P.I.: Roshan Bastani, PhD) $388,744, U.S. Department of Defense 1998 – 2000 Principal Investigator: Patient utilities for health states in early stage prostate cancer $461,000, American Cancer Society 1999 Principal Investigator: Quality of life in men treated for early stage prostate cancer $20,000, Stein-Oppenheimer Endowment for the Health Sciences 1999 – 2001 Research Career Development Award $150,000, Stop Cancer Foundation 1999 – 2001 Principal Investigator: Quality of life in men with early stage prostate cancer $648,043, California Department of Health Services, Cancer Research Program 2001 – 2003 Co-Investigator, Professional Education in Prostate Cancer Screening: Primary Care Providers (P.I.: Michael Wilkes, MD, PhD) $1,035,494, Centers for Disease Control 2001 – 2007 Principal Investigator, Urologic Diseases in America $7,211,942, National Institutes of Health (N01-DK-1-2460) 2001 – 2009 Principal Investigator: IMPACT: Improving Access, Counseling, & Treatment in Californians with Prostate Cancer $73,578,463 California Department of Health Services (Awards # 00-91891, 05-46124, 05-46234) [$49,357,133 (2001-03) + $11,100,000 (2003-05) + $2,400,000 (2005-06) + $10,721,330 (2006-09)] (about 10% of this budget is allocated for research efforts; the remainder underwrites patient care) 2002 – 2008 Co-Investigator, Survivor Quality-of-Life and Spouse Satisfaction after Prostate Therapy (P.I.:Martin Sanda, MD) $3,025,003, National Institutes of Health (R01-CA95662-01) $361,674 subcontract to UCLA (P.I.: Christopher S. Saigal, MD, MPH, Co-P.I.: Litwin) 2003 – 2006 Mentor and Co-Investigator, The Meaning of Incontinence and Impotence for Low Income African American and Latino Men with Prostate Cancer (P.I.: Sally L. Maliski, PhD, RN) $340,920, Department of Defense New Investigator Award 2003 – 2008 Principal Investigator: Chronic Prostatitis Collaborative Clinical Research Studies – II $1,600,000, National Institutes of Health (5 U01 DK 65257) 2005 – 2008 Mentor and Co-Investigator, Quality of Care Indicators for Early Stage Prostate Cancer (P.I.:Benjamin A. Spencer, MD, MPH) $699,605, Department of Defense New Investigator Award 2006 Principal Investigator, Assessing California's Prostate Cancer Treatment Resources for the Working Poor $25,000, California Program on Access to Care, University of California 2006 – 2007 Mentor, Unwarranted Surgical Variation for Early-Stage Kidney Cancer (P.I.: David C. Miller, MD, MPH) $50,000, American Cancer Society 2007 – 2009 Co-Investigator, Impact of Prostate Cancer Treatment-Related Symptoms on Low-Income Latino Couples (P.I.: Sally L. Maliski, RN, PhD) $463,500, Department of Defense 2007 – 2008 Principal Investigator: Reducing Prostate Cancer Treatment Barriers with Low Literacy Education Materials $75,000, California Attorney General’s Office 2007 – 2012 Principal Investigator, Urologic Diseases in America - II $7,000,000, National Institutes of Health (N01-DK-7-0003)
  3. 3. MARK S. LITWIN, MD, MPH Page 3 of 32 9/12/08 PUBLICATIONS IN REFEREED JOURNALS 1. Litwin MS, Graham SD: False positive hematuria. JAMA 1985;254:1724. 2. Bundy AL, Litwin MS, Gluck CD: Sonographic diagnosis of an obstructing urethral calculus. J Ultrasound Med 1988;7:523. 3. Litwin MS, Richie JP: Urology. JAMA 1989;261:2896-2897. 4. Litwin MS, Loughlin KR, Droege J, Benson CR: Placenta previa percreta invading the urinary bladder: report of three cases and review of the literature. Brit J Urol 1989;64:283-286. 5. Litwin MS, Kahn KL, Reccius N: Why do sicker patients cost more? A charge-based analysis of patients undergoing prostatectomy. J Urol 1993;149:84-88. 6. Litwin MS, Sacher SJ, Cohen WS: The Resource-Based Relative Value Scale: methods, results, and implications for urology. J Urol 1993; 150:981-987. 7. Litwin MS: Measuring health-related quality of life in men with prostate cancer. J Urol 1994;152:1882-1887. 8. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH: Quality of life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-135. 9. Litwin MS: Health-related quality of life after treatment for localized prostate cancer. Cancer 1995;75(Suppl):2000-2003. 10. Litwin MS: Urology. JAMA 1995;272:1725-1726. 11. Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O'Leary MP, Painter MR: Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. J Urol 1995;154:205-206. 12. Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O'Leary MP, Painter MR: Practice trends in the diagnosis and management of prostate cancer in the United States. J Urol 1995;154:207-208. 13. Smith RC, Litwin MS, Lu Y, Zetter BR. Identification of an endogenous inhibitor of prostatic carcinoma cell growth. Nature Med 1995;1:1040-1045. 14. Litwin MS, Smith RB, Thind A, Reccius N, Blanco-Yaroush M, deKernion JB: Cost-efficient radical prostatectomy with a clinical care path. J Urol 1996;155:989-993. 15. Moody JA, Litwin MS, Cochran ST, Moe A, Sahmedini D: Renal cavernous hemangioma in a patient with acquired immunodeficiency syndrome. J Urol 1996;156:1759-1760. 16. Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O'Leary MP, Painter MR, Blizzard RT, Fenninger RB, Emmons L: Practice trends of American urologists in the treatment of impotence, incontinence, and infertility. J Urol 1996;156:1778-1780. 17. Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R, Carroll PR: The CaPSURE Database: a methodology for clinical practice and research in prostate cancer. Urology 1996;48:773-777. 18. Litwin MS, Fine JT, Dorey F, Figlin RA, Belldegrun AS: Health-related quality of life outcomes in patients treated for metastatic kidney cancer: a pilot study. J Urol 1997;157:1608-1612. 19. Litwin MS, Shpall AI, Dorey F: Patient satisfaction with short stays for radical prostatectomy. Urology 1997;49:898-906. 20. Lubeck DP, Litwin MS, Henning JM, Carroll PR: Measurement of health-related quality of life in men with prostate cancer: data from the CaPSURE database. Qual Life Res 1997;6:385-392. 21. Gee WF, Holtgrewe HL, Albertsen PC, Cooper TP, Fenninger RB, Litwin MS, Manyak MJ, Meyer JJ, Miles BJ, O'Leary MP, Painter MR, Rohner TJ, Thomas R, Blizzard RT, Emmons L: Subspecialization, recruitment and retirement trends of American urologists. J Urol 1998; 159: 509-511.
  4. 4. MARK S. LITWIN, MD, MPH Page 4 of 32 9/12/08 22. Litwin MS, Nied RJ, Dhanani N: Health-related quality of life on men with erectile dysfunction. J Gen Int Med 1998; 13: 159-166. 23. Penson DF, Litwin MS, Lubeck DP, Flanders S, Pasta DJ, Carroll PR. Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer. Prost Ca Prost Dis 1998; 1:134-143. 24. Litwin MS, Lubeck DP, Henning JM, Carroll PR. Differences in urologist and patient assessments of health-related quality of life in men with prostate cancer: results from the CaPSURE database. J Urol 1998; 159; 1988-1992. 25. Litwin MS, Pasta DJ, Stoddard ML, Henning JM, Carroll PR. Epidemiological trends and financial outcomes in radical prostatectomy among Medicare beneficiaries, 1991 to 1993. J Urol 1998; 160: 445-448. 26. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: Development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002-1112. 27. Litwin MS, Shpall AI, Dorey F, Nguyen TH: Quality of life in men treated for metastatic prostate cancer. Am J Clin Oncol (CCT) 1998; 21: 327-332. 28. Krongrad A, Litwin MS, Lai H, Lai S: Dimensions of quality of life in prostate cancer. J Urol 1998;160:807-810. 29. Litwin MS, Penson DF: Health-related quality of life in men with prostate cancer. Prost Ca Prost Dis 1998; 1: 228-235. 30. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders S, Carroll PR: Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology 1999; 53:180-186. 31. Litwin MS, McGuigan KA, Shpall AI, Dhanani, N: Recovery of health-related quality of life in the year after radical prostatectomy: early experience. J Urol 1999; 161: 515-519. 32. Litwin MS: Urology. JAMA 1999; 281:495-496. 33. Litwin MS: Health-related quality of life in older men without prostate cancer. J Urol 1999; 161: 1180-1184. 34. Litwin MS, McNaughton-Collins MM, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA, Alexander RB, Farrar JT, O’Leary MP: The National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI): Development and validation of a new outcome measure. J Urol 1999; 162; 369-375. 35. Perrotte P, Litwin MS, Scott SM, Pisters LL. Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol 1999; 162: 398-402. 36. Cangiano TG, Litwin MS, Naitoh J, Dorey F, deKernion JB. Intraoperative frozen section monitoring of radical retropubic prostatectomy. J Urol 1999; 162: 655-658. 37. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM: Sexual function and bother after radical prostatectomy or radiation for prostate cancer: A multivariate quality of life analysis from CaPSURE. Urology 1999; 54: 503-508. 38. Litwin MS, Fitzpatrick JM, Fossa SD, Newling DWW. Defining an international research agenda for quality of life in men with prostate cancer. Prostate 1999; 41: 58-67. http://www3.interscience.wiley.com/cgi-bin/issuetoc?ID=63001096 39. Litwin MS, McGuigan K. Accuracy of recall in health-related quality of life assessment among men treated for prostate cancer. J Clin Oncol 1999; 17: 2882-2888. 40. Schultz MA, van Servellen G, Litwin MS, McLaughlin EJ, Uman GC. Can hospital structural and financial characteristics explain the variation in mortality in patients with acute myocardial infarction? Appl Nurs Res 1999; 12: 210-214. 41. Potosky AL, Harlan LC, Stanford JL, Gilliland FD, Hamilton AH, Albertsen PC, Liff JM, Stephenson RA, Legler J, Ferrans CE, Talcott JA, Litwin MS. The Prostate Cancer Outcomes Study (PCOS) Methods Part I: Construction of A Disease- Specific Quality of Life Index. J Nat Cancer Inst 1999; 91: 1719-1724.
  5. 5. MARK S. LITWIN, MD, MPH Page 5 of 32 9/12/08 42. Litwin MS. Examining health-related quality of life in men treated for prostate cancer. World J Urol 1999; 17: 205-210. 43. Lubeck DP, Litwin MS, Henning JM, Mathias SD, Bloor L, Carroll PR. An instrument to measure patient satisfaction with healthcare in an observational database: results of a validation study using data from CaPSURE. Am J Managed Care 2000; 6: 70-76. 44. Brandeis JM, Litwin MS, Burnison CM, Reiter RE. Quality of life after brachytherapy for early stage prostate cancer. J Urol 2000; 163: 851-857. 45. Brandeis JM, Pashos, C, Henning JM, Litwin MS. A nationwide charge comparison of the principal treatments for early stage prostate cancer. Cancer 2000; 89: 1792-1799. 46. Litwin MS, Pasta DJ, Yu J, Stoddard ML, Flanders SC. Urinary Function and Bother after Radical Prostatectomy or Radiation for Prostate Cancer: A Longitudinal, Multivariate Quality of Life Analysis From CaPSURE™ J Urol 2000; . 164: 1973-1977. 47. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer. Urology 2000; 56: 899-905. 48. Litwin MS, Lubeck DP, Stoddard ML, Pasta DJ, Flanders SC, Henning JM. Quality of life before death in men with prostate cancer: results from the CaPSURE database. J Urol 2001; 165: 871-875. 49. Grossfeld GD, Wolf JS, Litwin MS, Hricak H, Shuler CL, Agerter DC, Carroll PR. Asymptomatic Microscopic Hematuria in Adults: Summary of the AUA Best Practice Policy Recommendations. Am Fam Physician 2001; 63: 1145-54. 50. Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part I: definition, detection, prevalence, and etiology. Urology 2001; 57: 599-603. 51. Grossfeld GD, Litwin MS, Wolf JS, Hricak H, Shuler CL, Agerter DC, Carroll PR. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy-part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 2001; 57: 604-610. 52. Penson DF, Stoddard ML, Pasta DJ, Lubeck DP, Flanders SC, Litwin MS. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epidiol 2001; 54: 350-358. 53. Brandeis JM, Pashos, C, Henning JM, Litwin MS. Racial differences in the cost of treating men with early-stage prostate cancer. J Am Ger Soc 2001; 49: 297-303. 54. Penson DF, Schonfeld WH, Flanders SC, Henke CJ, Warolin KL, Carroll PR, Litwin MS. Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database Urology 2001; 57: 499-503. 55. Litwin MS, Melmed GY, Nakazon TT. Life after radical prostatectomy: a longitudinal study. J Urol 2001; 166: 587-592. 56. Saigal CS, Litwin MS, Gornbein J, Nease R. Predictors of utilities for health states in early stage prostate cancer. J Urol 2001; 166: 941-946. 57. Saigal CS, Gornbein J, Litwin MS. Patient utilities for complications do not predict treatment choice in men with clinically localized prostate cancer. J Clin Outcomes Man 2001;8:17-22. http://www.turner-white.com/pdf/jcom_aug01_prostate.pdf 58. Paige NM, Hays RD, Litwin MS, Rajfer J, Shapiro MF. Improvements in emotional well-being and relationships among users of sildenafil. J Urol 2001; 166: 1774-1778. 59. McNaughton Collins M, Pontari MA, O’Leary MP, Calhoun EA, Santanna J, Landis JR, Kusek JW, Litwin MS. Quality of life is impaired in men with chronic prostatitis: the chronic prostatitis collaborative research network. J Gen Int Med 2001; 16: 656-662.
  6. 6. MARK S. LITWIN, MD, MPH Page 6 of 32 9/12/08 60. McNaughton Collins M, O’Leary MP, Calhoun EA, Pontari MA, Adler A, Eremenco S, Chang CH, Odom L, Litwin MS. The Spanish NIH-Chronic Prostatitis Symptom Index: translation and linguistic validation. J Urol 2001; 166; 1800-1803. 61. Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG. Comprehensive comparison of health related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002; 20: 557-666. 62. Melmed GY, Kwan L, Reid K, Litwin MS. Quality of life at the end of life: trends in patients with metastatic prostate cancer. Urology 2002; 59: 103-109. 63. Berger AD, Kubak BM, Litwin MS, Shpiner, RS Levine ML, Pegues DA. Transitional cell carcinoma of the bladder two years after successful lung transplantation: case report and review of the literature. Urology 2002; 59: 296. 64. Saigal CS, Pashos CL, Henning JM, Litwin MS. Variations in use of imaging in a national sample of men with early stage prostate cancer. Urology 2002; 59: 400-404. 65. Freedland SJ, Blanco-Yarosh M, Sun JC, Hale SJ, Elashoff DA, Litwin MS, Smith RB, Rajfer J, Gritsch HA. Ketorolac- based analgesia improves outcomes for living kidney donors. Transplantation 2002; 73: 741-745. 66. Burkhardt JH, Litwin MS, Rose CM, Correa RJ, Sunshine JH, Hogan C, Hayman JA. Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early stage localized prostate cancer. J Clin Oncol 2002; 20: 2869-2875. 67. Cormier L, Kwan L, Reid K, Litwin MS. Knowledge and beliefs among brothers and sons of men with prostate cancer. Urology 2002; 59: 895-900. 68. Cormier L, Guillemin F, Valéri A, Fournier G, Cussenot O, Mangin P, Litwin MS. Impact of prostate cancer screening on health-related quality of life in at-risk families. Urology 2002; 59: 901-906. 69. Litwin MS, Lubeck DP, Spitalny GM, Henning JM, Carroll PR. Mental Health in Men Treated for Early Stage Prostate Cancer: A Post-Treatment, Longitudinal Quality of Life Analysis From CaPSURE. Cancer 2002; 95: 54-60. 70. Saigal CS, Gornbein J, Litwin MS. Stability of time tradeoff utilities for health states associated with the treatment of prostate cancer. Qual Life Res 2002; 11: 405-414. 71. Schaeffer AJ, Landis JR, Knauss JS, Propert KJ, Alexander RB, Litwin MS, Nickel JC, O’Leary MP, Nadler RP, Pontari MA, Shoskes DA, Zeitlin SI, Mazurick CA, Kishel L, Kusek JW, Nyberg LM. Demographic and clinical characteristics of men with chronic prostatitis: the NIH Chronic Prostatitis Cohort (CPC) study. J Urol 2002; 168: 593-598. 72. Schaeffer AJ, Knauss JS, Landis JR, Propert KJ, Alexander RB, Litwin MS, Nickel JC, O’Leary MP, Nadler RP, Pontari MA, Shoskes DA, Zeitlin SI, Fowler JE, Mazurick CA, Kusek JW, Nyberg LM. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the NIH Chronic Prostatitis Cohort (CPC) study. J Urol 2002; 168: 1048-1052. 73. Propert KJ, Alexander RB, Nickel JC, Kusek JW, Litwin MS, Landis JR, Nyberg LM, Schaeffer AJ. Design of a multi- center randomized clinical trial for chronic prostatitis /chronic pelvic pain syndrome. Urology 2002; 59: 870-876. 74. Saigal CS, Litwin MS. The economic costs of early stage prostate cancer. Pharmacoeconomics 2002;20(13):869-78. 75. Kakehi Y, Kamoto T, Ogawa O, Arai Y, Litwin MS, Suzukamo Y, Fukuhara S. Development of Japanese version of the UCLA Prostate Cancer Index: a pilot validation study. Int J Clin Oncol 2002; 7: 306-311. 76. Litwin MS. A review of the development and validation of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Urology 2002; 60 (Suppl 6A): 14-19. 77. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. The Role of Surgeon Volume in Radical Prostatectomy Outcomes. J Clin Oncol 2003; 21: 401-405.
  7. 7. MARK S. LITWIN, MD, MPH Page 7 of 32 9/12/08 78. Litwin MS, Saigal CS, Lubeck DP, Li Y, Henning JM, Carroll PR. Health related quality of life in men with metastatic prostate cancer: the misleading effect of lead time bias. Brit J Urol Int 2003; 91: 9-13. 79. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Temporal Trends In Radical Prostatectomy Complications from 1991-1998. J Urol 2003; 21: 1443-1448. 80. Miller DC, Litwin MS, Sanda MG, Montie JE, Dunn RL, Resh J, Sandler H, Wei JT. Use of quality indicators to evaluate localized prostate cancer care. Cancer 2003; 97: 1428-35. 81. Litwin MS. Quality of life following definitive therapy for localized prostate cancer: potential impact of multiple therapies. Curr Opin Urol 2003; 13: 153-156 82. Penson DF, Litwin MS, Aaronson NK. Health-related quality of life in men with prostate cancer. J Urol 2003; 169: 1653-61. 83. Penson DF, Litwin MS. The physical burden of prostate cancer. Urol Clin N Amer 2003; 30: 305-313. 84. Cormier L, Reid R, Kwan L, Litwin MS. Screening behavior in brothers and sons of men with prostate cancer. J Urol 2003; 169: 1715-1719. 85. Spencer BA, Steinberg M, Malin J, Adams J, Litwin MS. Quality of care indicators for early stage prostate cancer. J Clin Oncol 2003; 21: 1928-1936. 86. Korfage IJ, Essink-Bot ML, Madalinska JB, Kirkels WJ, Litwin MS, deKoning HJ. Measuring disease specific quality of life in localized prostate cancer: the Dutch experience. Qual Life Res 2003; 12: 459-464. 87. Hu JC, Kwan L, Saigal CS, Litwin MS. Regret In Men Treated For Localized Prostate Cancer. J Urol 2003; 169: 2279-83. 88. Krupski TL, Saigal CS, Litwin MS. Variation in continence and potency by definition. J Urol 2003; 170: 1291-1294. 89. Mehta SS, Lubeck DP, Pasta DJ, Litwin MS. Fear of Cancer Recurrence in Patients Undergoing Definitive Treatment for Prostate Cancer: Results from CaPSURE. J Urol 2003; 170: 1931-1933. 90. Penson DF, Litwin MS. Quality of life after treatment for prostate cancer. Curr Urol Rep 2003; 4:185-95. 91. Maliski SL, Clerkin B, Litwin MS. Describing a nurse case manager intervention to empower low-income men with prostate cancer. Oncol Nurs Forum 2004; 31: 57-64. 92. Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR, Litwin MS. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol 2004; 171: 703-707. 93. Cooperberg, MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR. The Contemporary management of prostate cancer in the United States: Lessons from CaPSURE, a national disease registry. J Urol 2004; 171: 1393-1401. 94. Cooperberg, MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll PR. Patterns of practice in the United States: Insights from CaPSURE on prostate cancer management. Curr Urol Rep 2004; 5: 166-172. 95. Calhoun EA, McNaughton Collins M, Pontari MA, O’Leary MP, Leiby B, Landis JR, Kusek JW, Litwin MS. The economic impact of chronic prostatitis: the chronic prostatitis collaborative research network. Arch Int Med 2004 164:1231-1236. 96. Maliski SM, Kwan L, Krupski T, Fink A, Orecklin J, Litwin MS. Confidence in the ability to communicate with physicians among low-income prostate cancer patients. Urology 2004; 64: 329-334. 97. Walling AM, Maliski S, Bogorad A, Litwin MS. Adequacy of prostate cancer patient education materials: Development of an evaluation tool. Patient Educ Couns 2004; 54: 337-343. 98. Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'Leary MP, Pontari MA, McNaughton-Collins M, Shoskes D, Comiter CV, Datta NS, Fowler JE, Nadler R, Zeitlin S, Knauss JS, Kusek JW, Nyberg LM, Litwin MS. A randomized
  8. 8. MARK S. LITWIN, MD, MPH Page 8 of 32 9/12/08 trial of ciprofloxacin and tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome. Ann Int Med 2004; 141: 581-589. 99. Litwin MS, Sadetsky N, Pasta DJ, Lubeck DL. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE. J Urol 2004; 172: 515-519. 100. Krupski TL, Smith MR, Lee WC, Pashos CL, Brandman J, Wang Q, Botteman B, Litwin MS. Natural history of bone complications in men with prostate cancer on androgen deprivation therapy. Cancer 2004; 101: 541-549. 101. Speight JL, Elkin E, Pasta DJ, Silva S, Lubeck DP, Carroll PR, Litwin MS. Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE. Int J Radiat Oncol Biol Phys 2004; 60: 1066-1075. 102. Weintraub D, Maliski SL, Fink A, Choe S, Litwin MS. Suitability of prostate cancer education materials: Applying a standard assessment tool to currently available materials. Patient Educ Couns 2004; 55: 275-280. 103. Spencer BA, Fung CH, Wang M, Litwin MS. Geographic variation across veterans affairs medical centers in the treatment of early-stage prostate cancer. J Urol 2004; 172: 2362-2365. 104. Maliski SL, Kwan L, Orecklin JR, Saigal CS, Litwin MS. Predictors of fatigue after treatment for prostate cancer. Urology 2005; 65: 101-108. 105. Litwin MS, Saigal CS, Yano EM, Avila C, Geschwind SA, Hanley JM, Joyce GF, Madison R, Pace J, Polich SM, Wang M. Urologic Diseases in America: analytic methods and principal findings. J Urol 2005; 173: 933-937. 106. Gore J, Krupski T, Kwan L, Fink A, Litwin MS. Mental health in low income, uninsured men with prostate cancer. J Urol 2005; 173: 1323-1326. 107. Eton DT, Lai J, Cella D, Reeve BB, Talcott JA, Clark JA, McPherson CP, Litwin MS, Moinpour CM. Data pooling and analysis to build a preliminary item bank: an example using bowel function in prostate cancer. Eval Health Prof 2005; 28: 142-159. 108. Cooperberg MR, Pasta DJ, Elkin EP, Litwin MS, Latini DM, DuChane J, Carroll PR. The UCSF Cancer of the prostate risk assessment (CAPRA) score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 2005; 173: 1938-1942. 109. Krupski TK, Fink A, Kwan L, Maliski S, Connor S, Clerkin B, Litwin MS. Health-related quality of life in low-income, uninsured men with prostate cancer. J Health Care Poor Underserved 2005; 16: 375-390. 110. Krupski T, Kwan L, Litwin MS. Sociodemographic factors associated with post-prostatectomy radiotherapy. Prost Ca Prost Dis 2005; 8: 184-188. 111. Gore JL, Krupski T, Kwan L, Maliski S, Litwin MS. Partnership status influences quality of life in men with prostate cancer. Cancer 2005; 104: 191-198. 112. Krupski TL, Sonn G, Kwan L, Maliski S, Fink A, Litwin MS. Ethnic variation in health related quality of life among low- income men with prostate cancer. Ethn Dis 2005; 15: 461-468. 113. Gacci M, Livi L, Detti B, Litwin MS, Bartoletti R, Giubilei G, Cai T, Mariani M, Carini M. Quality of life after radical treatment of prostate cancer: Validation of the Italian University of California, Los Angeles Prostate Cancer Index. Urology 2005; 66: 338-343. 114. Krupski TL, Bergman J, Kwan L, Litwin MS. Quality of prostate cancer care in a statewide public assistance program. Cancer 2005; 104: 985-982. 115. Gore JL, Kwan L, Saigal CS, Litwin MS. Marriage and mortality in bladder cancer. Cancer 2005; 104: 1188-1194.
  9. 9. MARK S. LITWIN, MD, MPH Page 9 of 32 9/12/08 116. Pontari MA, McNaughton-Collins M, O'Leary MP, Calhoun EA, Jang T, Knauss J, Kusek JW, Landis JR, Litwin MS. Epidemiologic risk factors in men with chronic pelvic pain syndrome: case-control study. BJU Int 2005;96:559-565. 117. Brar R, Kwan L, Maliski SL, Krupski T, Litwin MS. Changes in quality of life among low-income men treated for prostate cancer. Urology 2005; 66: 344-349. 118. Sonn GA, Aronson W, Litwin MS. Impact of diet on prostate cancer: a review. Prost Ca Prost Dis 2005; 8: 304-310. 119. Krupski TL, Kwan L, Afifi A, Litwin MS. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol 2005; 23: 7881-7888. 120. Krupski TL, Kwan L, Fink A, Sonn G, Maliski S, Litwin MS. Spirituality influences health related quality of life in men with prostate cancer. Psychooncology 2006; 15: 121-131. 121. Propert KJ, McNaughton-Collins M, Leiby BE, O’Leary MP, Litwin MS. A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the NIH chronic prostatitis cohort study. J Urol 2006; 175: 619-623. 122. Spencer BA, Babey SH, Etzioni DA, Ponce NA, Brown ER, Yu H, Chawla N, Litwin MS. A population-based survey of PSA testing among California men at higher risk for prostate cancer. Cancer 2006; 106; 765-774. 123. Anger JT, Saigal CS, Litwin MS. The prevalence of urinary incontinence among community-dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol 2006; 175: 601-604. 124. Anger JT, Saigal CS, Pace J, Rodriguez LV, Litwin MS. The true prevalence of urinary incontinence among female nursing home residents. Urology 2006; 67: 281-287. 125. Arredondo SA, Elkin EP, Marr PL, Latini DM, DuChane J, Litwin MS, Carroll PR. The impact of comorbidity on health- related quality of life in men undergoing radical prostatectomy: Data from CaPSURE. Urology 2006; 67: 559-65. 126. McNaughton-Collins M, Wang Y, Propert KJ, Alexander R, Calhoun E, Nickel JC, O’Leary MP, Pontari M, Litwin MS. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res. 2006; 15: 299-305. 127. Maliski SL, Connor S, Fink A, Litwin MS. Information desired and acquired by men with prostate cancer: data from ethnic focus groups. Health Educ Behav 2006; 33: 393-409. 128. Hu JC, Elkin EP, Krupski TL, Gore J, Litwin MS. The effect of post-prostatectomy external beam radiotherapy on quality of life: results from CaPSURE. Cancer 2006; 107:281-288. 129. Gore JL, Saigal CS, Handley JM, Litwin MS. Variations in reconstruction after radical cystectomy. Cancer 2006;107:729-737. 130. Krupski TL, Saigal C, Hanley J, Litwin MS. Patterns of care for men with prostate cancer following failure of primary treatment. Cancer 2006; 107: 258-265. 131. Anger JT, Saigal CS, Madison R, Joyce G, Litwin MS. Increasing costs of urinary incontinence among female Medicare beneficiaries. J Urol 2006; 176: 247-251. 132. Tripp DA, Nickel JC, Wang Y, Litwin MS, McNaughton-Collins M, Landis JR, Alexander RB, Schaeffer AJ, O’Leary MP, Pontari MA, Fowler JE, Nyberg LM, Kusek JW. Catastrophizing and pain-contingent rest as predictors of patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain 2006; 7: 697-708. 133. Maliski SM, Litwin MS. Unsolicited written comments in survey margins: an untapped data source. Oncol Nurs Forum 2007: 34: 142-174.
  10. 10. MARK S. LITWIN, MD, MPH Page 10 of 32 9/12/08 134. Anger JT, Maliski, SL, Krupski L, Kwan L, Gore JL, Fink A, Connor SE, Orecklin JR, Litwin MS. Outcomes in men denied access to a California public assistance program for prostate cancer. Pub Health Rep 2007; 122: 217-223. 135. Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. Complications of sling surgery among female Medicare beneficiaries. Obstet Gynecol 2007; 109: 707-714. 136. Miller DC, Spencer BA, Wei JT, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Litwin MS. Treatment choice and quality of care for men with localized prostate cancer. Med Care 2007; 45: 401-409. 137. Litwin MS, Greenfield S, Elkin EP, Lubeck DP, Broering JM, Kaplan SH. Assessment of prognosis with the Total Illness Burden Index for Prostate Cancer (TIBI-CaP): validation of an instrument to aid clinicians in treatment choice. Cancer 2007; 109: 1777-1783. 138. Anger JT, Rodriguez LV, Wang Q, Pashos CL, Litwin MS. The role of provider volume on outcomes after sling surgery for stress urinary incontinence. J Urol 2007; 177: 1457-1462. 139. Anger JT, Rodríguez LV, Wang Q, Chen E, Pashos CL, Litwin MS. Racial disparities in the surgical management of stress incontinence among female Medicare beneficiaries. J Urol 2007; 177: 1846-1850. 140. Miller DC, Spencer BA, Shah RB, Ritchey J, Stewart AK, Gay EG, Dunn RL, Wei JT, Litwin MS. The quality of surgical pathology care for men treated with radical prostatectomy in the United States. Cancer 2007; 109: 2445-2553. 141. Litwin MS, Gore J, Kwan L, Brandeis JM, Lee SP, Withers HR, Reiter RE. Quality of life following surgery, external beam irradiation, or brachytherapy for early stage prostate cancer. Cancer 2007; 109: 2239-2247. 142. Anger JT, Saigal CS, Stothers L, Thom DH, Rodriguez LV, Litwin MS. The prevalence of urinary incontinence among community-dwelling adult men: results from the National Health and Nutrition Examination Survey. J Urol 2006; 176: 2103-2108. 143. Deibert C, Maliski S, Kwan L, Fink A, Connor SE, Litwin MS. Prostate cancer knowledge among low-income, minority men. J Urol 2007; 177: 1851-1855. 144. Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. Variations in stress incontinence and prolapse management by surgeon specialty. J Urol 2007; 178: 1411-1417. 145. Krupski TL, Foley KA, Baser O, Ling S, Macarios D, Litwin MS. Health care cost associated with prostate cancer, androgen deprivation therapy, and bone complications. J Urol 2007; 178: 1423-1428. 146. Saigal CS, Gore JL, Krupski TL, Hanley J, Schonlau M, Litwin MS. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer 2007; 110: 1493-1500. 147. Anger JT, Rodríguez LV, Wang Q, Pashos CL, Litwin MS. The role of pre-operative testing on outcomes after sling surgery for stress urinary incontinence. J Urol 2007; 178: 1364-1368. 148. Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. The effect of age on outcomes of sling surgery for urinary incontinence. J Gen Int Med 2007; 55: 1927-1931. 149. Zavala MW, Maliski SL, Kwan L, Miller DC, Fink A, Litwin MS. Longitudinal quality of life in low-income men in a state- funded prostate cancer treatment program. J Health Care Poor Underserved 2008; 19: 200-214. 150. Wright J, Lin DW, Cowan JE, Litwin MS. Quality of life in young men after radical prostatectomy: Results from CaPSURE. Prost Ca Prost Dis 2008; 11: 67-73. 151. Namiki S, Kwan L, Kagawa-Singer M, Saito S, Terai A, Satoh T, Baba S, Arai Y, Litwin MS. Sexual function reported by Japanese and American men. J Urol 2008; 179: 245-249.
  11. 11. MARK S. LITWIN, MD, MPH Page 11 of 32 9/12/08 152. Miller DC, Schonlau M, Litwin MS, Lai J, Saigal CS. Renal and cardiovascular morbidity following partial or radical nephrectomy. Cancer 2008; 112: 511-520. 153. Namiki S, Kwan L, Kagawa-SingerM, Tochigi T, Ioritani N, Terai A, Arai Y, Litwin MS. Sexual function following radical prostatectomy: a prospective longitudinal study of cultural differences between Japanese and American men. Prost Ca Prost Dis 2008. In press. 154. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters L, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate cancer survivors and their spouses. N Engl J Med 2008; 358: 1250-1261. 155. Nickel JC, Tripp DA, Chuai S, Litwin MS, McNaughton-Collins M, Landis JR, Alexander RB, Schaeffer AJ, O’Leary MP, Pontari MA, White P, Nyberg LM, Kusek J, Mullins C. Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). BJU Int 2008; 101: 59-64. 156. Miller DC, Saigal CS, Banarjee M, Hanley J, Litwin MS. Diffusion of surgical innovation among patients with kidney cancer. Cancer 2008; 112: 1708-1717. 157. van de Poll-Franse LV, Kwan L, Reiter RE, Lee SP, Litwin MS. The influence of cardiovascular disease on health-related quality of life in men with prostate cancer: a 4 year follow-up study. J Urol 2008; 179: 1362-1367. 158. Taylor BC, Noorbaloochi S, Saigal CS, Sohn MW, Pontari MA, McNaughton-Collins M, Litwin MS, Wilt TJ. Excessive antibiotic use in men with prostatitis. Amer J Med 2008; 121: 444-449. 159. Hu JC, Kwan L, Krupski T, Litwin MS. Determinants of treatment regret in low-income, minority men with prostate cancer. Urology 2008 (Feb 28 e-pub ahead of print). 160. Namiki S, Kwan L, Kagawa-Singer M, Litwin MS. The effect of erectile function on the use of PDE-5 inhibitors after radical prostatectomy in Japanese and American men. Urology 2008; 71: 901-905. 161. Maliski SL, Kwan L, Elashoff D, Litwin MS. Symptom clusters related to prostate cancer treatment. Oncol Nurs Forum 2008; 35: 786-793. 162. Miller DC, Gelberg L, Kwan L, Stepanian S, Fink A, Andersen RM, Litwin MS. Racial disparities in access to care for men in a public assistance program for prostate cancer. J Comm Health 2008; 33: 318-335. 163. D’Avolio LW, Litwin MS, Rogers SO, Bui AAT. Facilitating clinical outcomes assessment through the automated identification of quality measures for prostate cacner surgery. J Amer Med Inform Assoc 2008; 15: 341-348. 164. Spencer BA, Miller DC, Litwin MS, Ritchey J, Stewart AK, Dunn RL, Sandler HM, Wei JT. Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol 2008; 26: 3735-3742. 165. Namiki S, Kwan L, Kagawa-Singer M, Terai A, Arai Y, Litwin MS. Urinary quality of life after prostatectomy or radiation for localized prostate cancer: a prospective longitudinal crosscultural study between Japanese and American men. Urology 2008; 71: 1103-1108. 166. Namiki S, Kwan L, Kagawa-Singer M, Terai A, Satoh T, Baba S, Arai Y, Litwin MS. Distress and social dysfunction following prostate cancer treatment: a longitudinal cross-cultural comparison of Japanese and American men. Prost Ca Prost Dis 2008 (Apr 8 e-pub ahead of print). 167. Anger JT, Litwin MS, Wang Q, Pashos CL, Rodríguez LV. The effect of concomitant sling repair on prolapse outcomes. Urology 2008; 180: 1003-1006. 168. van de Poll-Franse LV, Sadetsky N, Kwan L, Litwin MS. Severity of cardiovascular disease and health-related quality of life in men with prostate cancer: a 4 longitudinal analysis from CaPSURE. Qual Life Res 2008; 17: 845-855.
  12. 12. MARK S. LITWIN, MD, MPH Page 12 of 32 9/12/08 169. Maliski SL, Rivera S, Connor SE, Lopez G, Litwin MS. Renegotiating masculine identity after prostate cancer treatment. Qual Health Res 2008. In press. 170. Simone NL, Singh AK, Cowan JE, Soule BP, Carroll PR, Litwin MS. Pre-treatment predictors of death from other causes in men with prostate cancer. J Urol 2008. In press. 171. Nickel JC, Krieger J, White PC, McNaughton-Collins M, O’Leary MP, Anderson RU, Nadler R, Pontari M, Shoskes DA, Litwin MS, Zeitlin S, Alexander RB, Berger R; Liong ML, Chuai S, Landis JR, Kusek JW, Nyberg LM Schaeffer AJ. Effect of Alfuzosin on symptoms in men with chronic prostatitis / chronic pelvic pain syndrome. N Engl J Med 2008. In press. 172. Miller, DC, Litwin MS, Bergman J, Stepanian S, Connor SE, Kwan L, Aronson WJ. Prostate cancer severity among low- income, uninsured men. J Urol 2008. In press. 173. White WM, Sadetsky N, Waters WB, Carroll PR, Litwin MS. Quality of life among men with locally advanced adenocarcinoma of the prostate. J Urol 2008. In press. 174. Zavala MW, Maliski SL, Kwan L, Fink A, Litwin MS. Spirituality and quality of life in low-Income men with metastatic prostate cancer. Psychooncology 2008. In press. 175. Gore JL, Lai J, Setodji CM, Litwin MS, Saigal CS. Mortality increases when radical cystectomy is delayed more than 12 weeks: Results from a SEER-Medicare analysis. Cancer 2008. In press. 176. Bergman J, Kwan L, Fink A, Connor SE, Litwin MS. Hospice and emergency room use by disadvantaged men dying of prostate cancer. J Urol 2009. In press. PEER-REVIEWED MONOGRAPHS 1. Kallich JD, Litwin MS, Markovich M. Vascular access procedures for end-stage renal disease Medicare beneficiaries. Santa Monica, CA: RAND, 1995. 2. Litwin MS, Steinberg M, Malin J, Naitoh J, McGuigan KA, Steinfeld R, Adams J, Brook RH. Prostate cancer patient outcomes and choice of providers: development of an infrastructure for quality assessment. Santa Monica, CA: RAND, 2000. Available online at http://www.rand.org/publications/MR/MR1227/ 3. Institute of Medicine. 2004. Testosterone and Aging: Clinical Research Directions. Washington, DC: National Academies Press. Available on line at www.nap.edu/catalog/10852.html 4. Institute of Medicine. 2006. From Cancer Patient to Cancer Survivor: Losty in Transition. Washington, DC: National Academies Press. Available on line at www.iom.edu/CMS/28312/4931/30869.aspx BOOKS 1. Litwin MS: How to Measure Survey Reliability and Validity, Thousand Oaks: Sage Publications, 1995. 2. Litwin MS: How to Assess and Interpret Survey Psychometrics, Thousand Oaks: Sage Publications, 2003. 3. Litwin MS, Saigal CS, eds. Urologic Diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Publishing Office, 2004 and 2007; NIH Publication No. 04-5512 MANUSCRIPTS SUBMITTED FOR PUBLICATION 1. Brucker PS, Bode RK, Eton D, Talcott J, Clark J, Knight S, Litwin MS, Moinpour CM, Reeve B, Aaronson N, Bennett C, Herr H, McGuire M, McPherson C, Shervin D, Cella D. Classifying and refining measurement of urinary incontinence, irritation, and obstruction in prostate cancer. 2. Ritchey J, Gay G, Spencer BA, Miller DC, Wallner L, Stewart A, Dunn R, Litwin MS, Wei JT. The quality of medical care in prostate cancer patients choosing expectant management.
  13. 13. MARK S. LITWIN, MD, MPH Page 13 of 32 9/12/08 3. Calhoun EA, Clemens JQ, Litwin MS, Walker-Corkery E, Markossian T, Kusek JW, McNaughton-Collins M. Primary care physician practices in the diagnosis, treatment and management of men with chronic prostatitis / chronic pelvic pain syndrome. 4. Anger JT, Rodríguez LV, Weinberg AE, Gore JL, Wang Q, Pashos CL, Leonardi M, Litwin MS. Thromboembolic complications of sling surgery: a call for DVT prophylaxis. 5. Namiki S, Litwin MS, Kwan L, Kagawa-Singer M, Ishidoya S, Ito A, Saito S, Arai Y. Association of lower urinary tract symptoms with sexual dysfunction: a cross-cultural study between Japanese and American men with localized prostate cancer. 6. Augustus JS, Kwan L, Fink A, Maliski S, Connor SE, Litwin MS. Education as a predictor of quality-of-life outcomes among disadvantaged men. 7. Miller, DC, Saigal CS, Warren JL, Leventhal M, Deapen D, Banarjee M, Lai J, Hanley J, Litiwn MS. Validation of a claims-based algorithm for identifying kidney-cancer surgeries. 8. Gore JL, Litwin MS. Quality of care in bladder cancer: Trends in urinary diversion following radical cystectomy. 9. Gore JL, Danovitch GM, Litwin MS, Pham PT, Singer JS. Disparaties in the utilization of live donor renal transplantation. 10. Bergman J, Gore JL, Penson DF, Kwan L, Litwin MS. Erectile aid use by men treated for localized prostate cancer. 11. Bergman J, Logan S, Fink A, Ganz DA, Peterson MA, Litwin MS. Caring for the uninsured with prostate cancer: a comparison of four policy alternatives in California. 12. Bergman J, Gore JL, Saigal CS, Kwan L, Litwin MS. Partnership and outcomes in men with prostate cancer. 13. Gore JL, Yu H, Setodji C, Hanley JM, Litwin MS, Saigal CS. Urinary diversion and morbidity following radical cystectomy for bladder cancer. 14. Bergman J, Gore JL, Saigal CS, Kwan L, Litwin MS. Partnership and outcomes in men with prostate cancer.
  14. 14. MARK S. LITWIN, MD, MPH Page 14 of 32 9/12/08 SCIENTIFIC EDITORIALS 1. Litwin MS, deKernion JB: Perspectives on the problem of prostate cancer. J Urol 1994: 1680-1681. 2. Litwin MS: Editorial comment: Impact of a collaborative care approach to radical cystectomy and urinary reconstruction. J Urol 1995; 154: 1001. 3. Litwin MS: Editorial comments on prostate cancer. In deKernion JB, Howards SS, eds., The Yearbook of Urology, 1995, St. Louis, MO: Mosby-Year Book, Inc., 165, 166-169, 172, 200, 1995. 4. Litwin MS: Editorial comment: Psychosocial aspects in long-term survivors of testicular cancer. J Urol 1996; 155: 578. 5. Litwin MS: Editorial comments on prostate cancer. In deKernion JB, Howards SS, eds., The Yearbook of Urology, 1996, St. Louis, MO: Mosby-Year Book, Inc., 193-195, 314-316, 1996. 6. Litwin MS: Editorial comment: Natural history of prostatism: impaired health states in men with lower urinary tract symptoms. J Urol 1997; 157: 1717. 7. Litwin MS: Editorial comment: The psychosocial impact of donating a kidney. J Urol 1997; 157: 1600-1601. 8. Litwin MS: Editorial comment: Reliability of Spanish translations of selected urological quality of life instruments. J Urol 1997;158:496 9. Litwin MS: Editorial comment: QOL and outcomes research in prostate cancer patients with low socioeconomic status. Oncology 1999; 13: 836-838. 10. Litwin MS: Symptom Index for Chronic Prostatitis: Use in Clinical Practice. AUA News 1999; 4:1. 11. Litwin MS: Editorial comment: Counseling cancer patients about changes in sexual function. Oncology 1999; 13: 1591-95. 12. Litwin MS: Measuring quality of life after prostate cancer treatment. Ca J Sci Am 1999; 5: 211-213. 13. Litwin MS: Editorial comment: Differences in sexual function and quality of life after nerve sparing and non-nerve sparing radical retropubic prostatectomy. J Urol 2000; 163: 1169. 14. Litwin MS: Editorial comment: Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life – a structured debate. J Urol 2000; 163: 1806-1807. 15. Litwin MS: Editorial comment: Using outcome data and patient satisfaction surveys to develop policies regarding minimum length of hospitalization after radical prostatectomy. Urology 2000; 56: 106-107. 16. Litwin MS: Editorial comment: The cost value of medical versus surgical hormonal therapy for metastatic prostate cancer. J Urol 2000; 164: 737. 17. Litwin MS: Editorial comment: Prospective assessment of patient-reported urinary continence after radical prostatectomy. J Urol 2000; 164: 748. 18. Ganz PA, Litwin MS: Prostate cancer: the price of early detection. J Clin Oncol 2001; 19: 1587-88. 19. Litwin MS: Editorial comment: Life after radical prostatectomy: a longitudinal study. J Urol 2002; 168: 203-204. 20. Litwin MS: Editorial comment: Variation in continence and potency by definition. J Urol 2004; 171: 1635. 21. Litwin MS, Saigal CS, Beerbohm EM. The burden of urologic diseases in America. J Urol 2005; 173: 1065-1066. 22. Litwin MS. Discharging our duty. J Urol 2006; 175: 1604. 23. Litwin MS, Miller DC. Treating older men with prostate cancer: survival (or selection) of the fittest? JAMA 2006; 296: 2733-34. 24. Litwin MS. Editorial comment: The evolving presentation of renal cell carcinoma in the United States. J Urol 2006; 176: 2400. 25. Litwin MS. Editorial comment: Preoperative and intraoperative risk factors associated with 30-day morbidity following urological surgery. J Urol 2006; 176: 2186. 26. Litwin MS. Editorial comment: The distribution of histologic subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol 2008; 179: 444. 27. Litwin MS. Commentary on urinary and sexual outcomes after radical prostatectomy. J Urol 2008; 179 (5 Suppl): S45- S46. 28. Litwin MS. Editorial comment: Determinants of quality of life for patients with kidney stones. J Urol 2008; 179: 2243. 29. Litwin MS. Editorial comment: Health risk behaviors and PSA awareness among men in California. J Urol 2008; 180: 662. CHAPTERS 1. Litwin MS, Richie JP: Surveillance in patients with stage I nonseminomatous testicular tumors. In Nyhus L, ed., Surgery Annual, Norwalk, CT: Appleton & Lange, 89-99, 1994. 2. Litwin MS, Richie JP: Surgical technique in orchiectomy and retroperitoneal lymphadenectomy. In Karakousis CP, Copeland EM, Bland KL, eds., Atlas of Surgical Oncology, Philadelphia: WB Saunders Co., 632-638, 1995.
  15. 15. MARK S. LITWIN, MD, MPH Page 15 of 32 9/12/08 3. Litwin MS: Analyzing health-related quality of life. In Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, eds., Comprehensive Textbook of Genitourinary Pathology, Baltimore, MD: Williams & Wilkins, 15-21, 1995. 4. Ganz PA, Litwin MS: Measuring outcomes and health-related quality of life. In Andersen RM, Rice TH, Kominski GF, eds., Changing the U.S. Health Care System: Key Issues in Health Services, Policy, and Management. San Francisco, CA: Josey-Bass Publishers, 120-141, 1996. 5. Litwin MS, Fuchs GJ, Rajfer J: Prostate Disease. In Bongard F, Stamos M, Passaro E, eds., Harbor Textbook of Surgery, Churchill Livingstone Publishers, 545-552, 1996. 6. Fuchs, GJ, Litwin MS, Rajfer J: Nephrolithiasis and Obstruction. In Bongard F, Stamos M, Passaro E, eds., Harbor Textbook of Surgery, Churchill Livingstone Publishers, 553-558, 1996. 7. Litwin MS, Fuchs GJ, Rajfer J: Urologic neoplasms. In Bongard F, Stamos M, Passaro E, eds., Harbor Textbook of Surgery, Churchill Livingstone Publishers, 559-563, 1996. 8. Litwin MS, Fuchs GJ, Rajfer J: Urologic trauma. In Bongard F, Stamos M, Passaro E, eds., Harbor Textbook of Surgery, Churchill Livingstone Publishers, 565-568, 1996. 9. Litwin MS: The cost of treating urologic malignancies. In Raghavan D, Scher HI, Liebel SA, Lange P, eds., Principles and Practice of Genitourinary Oncology, JB Lippincott, 175-181, 1997. 10. Litwin MS: Assessing health-related quality of life in patients with genitourinary malignancies. In Pienta KJ, ed., Cancer Treatment and Research, Kluwer Academic Publishers, 249-264, 1996. 11. Litwin MS, Penson DF: Health-related quality of life in men with prostate cancer: methodological considerations and practical applications. In Belldegrun AS, Kirby RI, eds., New Perspectives in Prostate Cancer. Oxford: Isis Medical Media, Ltd., 391-401, 1998. 12. Penson DF, Litwin MS: Assessing quality of life: surgery versus radiation. In Klein EA, ed., Management of Prostate Cancer, Totowa, NJ: Humana Press, 183-198, 2000. 13. Litwin MS, Saigal CS: Assessing patient utilities in men with prostate cancer. In Belldegrun AS, Kirby RI, eds., New Perspectives in Prostate Cancer. Oxford: Isis Medical Media, Ltd., 307-316, 2000. 14. Barry MJ, Litwin MS, Aaronson NK, Bunyaratavej P, Calais da Silva F, Fossa SD, Krongrad A, Lobel B, Mebust WK, Trachtenberg JT, Zerbib M. Quality of life. In Murphy G, Khoury S, Partin A, Denis L, eds., Prostate Cancer. Plymouth, UK: Plymbridge Distributors, Ltd., 451-479, 2000. 15. Penson DF, Litwin MS: The impact of urologic complications on quality of life. In Taneja, SS, Smith RB, Ehrlich, RM, eds., Complications of Urologic Surgery, 3rd edition. Philadelphia: WB Saunders Co, 56-66, 2000. 16. Ganz PA, Litwin MS, Meyerowitz BE. Sexual health and functioning after cancer. In DeVita VT, Hellman S, Rosenberg SA, eds., Cancer: Principles and Practice of Oncology, Philadelphia: Lippincott Williams & Wilkins, 3032-49, 2001. 17. Ganz PA, Litwin MS: Measuring outcomes and health-related quality of life. In Andersen RM, Rice TH, Kominski GF, eds., Changing the U.S. Health Care System: Key Issues in Health Services, Policy, and Management, second edition. San Francisco, CA: Josey-Bass Publishers, 127-149, 2001. 18. Litwin MS: Analyzing health-related quality of life. In Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS, eds., Comprehensive Textbook of Genitourinary Pathology, 2nd edition, Baltimore, MD: Lippincott Williams & Wilkins, 16-21, 1999. 19. Litwin MS, Reid K: Quality of life and health behavior in prostate cancer screening populations. In Thompson IM, Resnick MI, Klein EA, eds., Textbook of Prostate Cancer Screening, Humana Press, 187-208, 2001. 20. Talcott JA, Litwin MS: Quality of life in prostate cancer. In Kantoff PW, Carroll P, D’Amico A, eds., Prostate Cancer, Philadelphia: Lippincott Williams & Wilkins, 368-381, 2002. 21. Rosen R, Hatzichristou D, Broderick G, Clayton A, Cuzin B, Derogatis L, Litwin M, Meuleman E, O’Leary M, Quirk F, Sadovsky R, Seftel A. Clinical evaluation and symptom scales: sexual dysfunction assessment in men. In Lue TF, Basson R, Rosen R, Giuliano F, Khoury S, Montorsi F, eds., Sexual Medicine: Sexual Dysfunction in Men and Women, Paris: Editions 21, 173-222, 2004. 22. Litwin, MS, Talcott, JA. Measuring quality of life in prostate cancer: progress and challenges. In Lipscomb J, Gotay CC, Snyder C, eds., Outcomes Assessment in Cancer, Cambridge: Cambridge University Press, 126-159, 2005. 23. Saigal CS, Litwin MS: Epidemiology of female urinary incontinence. In Vasavada SP, Appell RA, Sand P, Raz S, eds., Female Urology, Urogynecology, and Voiding Dysfunction, New York: Marcel-Dekker, Inc., 45-51, 2005. 24. Penson DF, Litwin MS: Health-related quality of life in female urinary incontinence. In Vasavada SP, Appell RA, Sand P, Raz S, eds., Female Urology, Urogynecology, and Voiding Dysfunction, New York: Marcel-Dekker, 53-64, 2005. 25. Krupski TL, Litwin MS: Medical and psychosocial issues in prostate cancer survivors. In Chang AE, Ganz PA, Hayes DF, et al, eds., Oncology – An Evidence-Based Approach, New York: Springer Science+Business Media, 1859-1870, 2006. 26. Litwin MS. Health related quality of life. In Wei JT, Penson DF, eds., Clinical Research Methods for Surgeons, Totowa NJ: Humana Press, 237-251, 2006. 27. Litwin MS. Outcomes research. In Partin A, et al, eds. Campbell’s Urology, Philadelphia: WB Saunders Co, 144-158, 2007.
  16. 16. MARK S. LITWIN, MD, MPH Page 16 of 32 9/12/08 OTHER PUBLICATIONS 1. Litwin MS: Communication in Medicine. JAMA 1984;252:2116D (PULSE Suppl). 2. Litwin MS: AAMC Panel Calls for Broader Medical Education. JAMA 1984;252:3340D (PULSE Suppl). 3. Litwin MS: Adding Life to Years. Medicine at Emory, July 1984. 4. Litwin MS: Eyes. Atlanta Medicine, July 1984. 5. Litwin MS: Laser Light. Medicine at Emory, May 1985. 6. Litwin MS: The Cover: Georges Braque's “Aria de Bach.” JAMA 1985;254:465. 7. Litwin MS: Physicians' group seeks nuclear arms ban. JAMA 1985;254:586-591. 8. Litwin MS: A Piece of My Mind: The Waiting Room. JAMA 1985;254:2758. 9. Breedlove C, Litwin MS: The Cover: Jules Olitski's “Born in Snovsk.” JAMA 1986;255:7. 10. Litwin MS: A guitar is a violin is a feeling is an essay. JAMA 1986;255:325. 11. Litwin MS: The Cover: May Lesser's “Grand Rounds.” JAMA 1987;257:21. 12. Litwin MS: A Piece of My Mind: Max. JAMA 1987;257:2210. 13. Litwin MS: The Cover: Willard Metcalf's “Old Homestead, Connecticut” JAMA 1987;258:1858. 14. Litwin MS: The Waiting Room. In Dan BB and Young RK, eds., A Piece of My Mind: A Collection of Essays from the Journal of the AMA, Los Angeles: Feeling Fine, Inc., 136-138, 1988. 15. Litwin MS: Max. In Dan BB and Young RK, eds., A Piece of My Mind: A Collection of Essays from the Journal of the AMA, Los Angeles: Feeling Fine, Inc.,200-202, 1988. 16. Litwin MS: Introducing the ‘Resident Forum.’ JAMA 1989;262:1377. 17. Litwin MS: 100,000 and counting. JAMA 1989;262:2546. 18. Litwin MS: Patients to benefit from reforms for interns. The New York Times: January 10, 1990, p 26. 19. Litwin MS: A resident's reflections on medical education. JAMA 1991;266:926. 20. Litwin MS: Ode To Joy. Ann Int Med 1992;117:337. 21. Litwin MS: AMA addresses resident issues. AUA Today, February 1992. 22. Litwin MS: Young urologists can help abolish unequal Medicare payments. AUA Today, November 1992. 23. Litwin MS: New regulations on student loan deferments now in effect. AUA Today, December 1992. 24. Leach GE, Blaivas JG, Diokno AC, Litwin MS: Managing incontinence by the book. Contemp Urol 1993; 5:16-34. 25. Litwin MS: When to discuss advance directives. Ann Int Med 1993;118:475. 26. Litwin MS: Student loan deferment update. JAMA 1993;270:27. 27. Litwin MS: Informed consent for tests for prostate cancer. JAMA 1995;274:128. 28. Litwin MS: AMA council confronts health care system policy and politics. AUA Today, September, 1995. 29. Litwin MS: Ode to Joy. In LaCombe MA, ed, On Being A Doctor. Philadelphia: American College of Physicians, 119-120, 1995. 30. Penson DF, Litwin MS: Health-related quality of life in patients with urologic cancers. American Urological Association: AUA Update Series 1997;16:5. 31. Penson DF, Litwin MS: Quality of life assessment in patients with urological disease. Contemp Urol 1997;9:53-66. 32. Litwin MS: The impact of cost-outcomes research on the treatment of men with prostate cancer. Contemp Urol 1997;9:43-50. 33. Litwin MS: Economic realities of prostate cancer management. Internal Med 1997;18:75-83. 34. Litwin MS: Topics no longer taboo. North Carolina Med J 1997;58:232 (letter). 35. Litwin MS, Flanders SC: Sexual function after radiation therapy or radical prostatectomy: results from the CaPSURE database. AUA News 1998;3:1. 36. Litwin MS: Editorial comment: Radical prostatectomy improves obstructive voiding symptoms. J Urol 1999;162:1188. 37. Penson DF, Litwin MS: Predicting quality of life after treatment for prostate cancer. Urol News 1999; 3: 6-8. 38. Penson DF, Litwin MS: Quality of life after treatment for localized prostate cancer. Contemp Urol 2000; 12: 35-43. 39. Nickel JC, Mcnaughton-Collins M, Litwin MS. Development and use of a validated outcome measure for chronic prostatitis. J Clin Outcomes Man; 2001; 8: 30-37. 40. Litwin MS: What do I do with this abnormal PSA? Fam Pract Recert 2001; 23: 16-20. 41. Penson DF, Litwin MS: Quality of life issues in patients with prostate cancer. American Urological Association: AUA Update Series 2001. 42. Grossfeld GD, Wolf JS, Litwin MS, Hricak H, Shuler CL, Agerter DC, Carroll PR. American Urological Association Best Practice Policy: Evaluation of Asymptomatic Microscopic Hematuria in Adults. AUA Update Series 2001. 43. Litwin MS: Testicular self examination. In Breslow, L. ed. Encyclopedia of Public Health. Detroit & New York: Macmillan Reference USA, 1187, 2002. 44. Gore JL, Penson DF, Litwin MS. Discussing quality-of-life issues in men with newly diagnosed prostate cancer. Nature Clin Prac Urol 2006; 3:449-52.
  17. 17. MARK S. LITWIN, MD, MPH Page 17 of 32 9/12/08 45. Nickel JC, Alexander RB, Anderson R, Berger R, Comiter CV, Datta NS, Fowler JE, Krieger JN, Landis JR, Litwin MS McNaughton-Collins M, O’Leary MP, Pontari MA, Schaeffer AJ, Shoskes DA, White P, Kusek J, Nyberg LM. Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies. Curr Prost Rep 2007; 5: 141-148. 46. Litwin MS. Health services research. Semin Radiat Oncol 2008; 18: 152-160. 47. Cooperberg MR, Birkmeyer JD, Litwin MS. Defining high quality care. Semin Urol Oncol 2008. In press. 48. Miller DC, Saigal CS, Litwin MS. The demographic burden of urologic diseases in America. Urol Clin N Amer 2008. In press. 49. Connor SE, Maliski SL, Litwin MS. Access to health care and quality of life in prostate cancer: a five-year review. Nature Clin Prac Urol 2008. In press. PUBLISHED ABSTRACTS AND SCIENTIFIC PRESENTATIONS 1. Litwin MS, Klein LA: Persistent detrusor contraction. 1988 Annual meeting of the AUA New England Section. 2. Litwin MS, Chackal-Roy M, Zetter B: Regulation of prostatic carcinoma cell growth. 1989 Annual meeting of theAUA New England Section. 3. Litwin MS, Chackal-Roy M, Richie JP, and Zetter B: A tumor cell growth inhibitor found in benign prostate tissue. 1990 Annual meeting of the American Urological Association, J Urol 1990;143:240A. 4. Litwin MS, Chackal-Roy M, Richie JP, and Zetter B: A tumor cell growth inhibitor found in benign prostate tissue. 1990 Surgical Forum of the American College of Surgeons. 5. Litwin MS, Breslow L: Decreased racial differences in the incidence and mortality of prostate cancer: a phenomenon of increasing age. 1992 Annual meeting of the American Urological Association, J Urol 1992;147:469A. 6. Litwin MS, Kahn KL, Reccius N: Why do sicker patients cost more? A charge-based analysis of patients undergoing prostatectomy. 1992 Annual meeting of the AUA Western Section. 7. Litwin MS, Kahn KL, Reccius N: Why do sicker patients cost more? A charge-based analysis of patients undergoing prostatectomy. 1992 Annual meeting of the Robert Wood Johnson Foundation Clinical Scholars Program. 8. Litwin MS, Fink A, Hays RD, Ganz PA, Brook RH, Duan N, Rosenthal JT, deKernion JB: Quality of life in men with prostate cancer: A pilot study. 1993 Annual meeting of the American Urological Association, J Urol 1993;149:494A. 9. Litwin MS, Hays RD, Fink A, Brook RH: Defining quality of life in men with prostate cancer. 1993 Annual meeting of the Robert Wood Johnson Foundation Clinical Scholars Program. 10. Litwin MS, Hays RD, Fink A, Leach G, Duan N, Brook RH: Health related quality of life in men with prostate cancer. 1995 Annual meeting of the American Urological Association. J Urol 1995;153:251A. 11. Litwin MS, Greenfield S, Chodak G: Observation as management for early prostate cancer. 1995Annual meeting of the American Society of Clinical Oncology. 12. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH: Quality of life outcomes in men treated for localized prostate cancer (JAMA 1995;273:129-135). In deKernion JB, Howards SS, eds., The Yearbook of Urology, 1995, St. Louis, MO: Mosby-Year Book, Inc., 201-202, 1995. 13. Litwin MS, Dhanani N: Differences in resource utilization from urinary tract infection among patients treated by primary care physicians or urologists. 1996 Annual meeting of the American Urological Association, J Urol 1996;155:453A. 14. Litwin MS, Smith RB, Thind A, Reccius N, Blanco-Yarosh M, deKernion JB: Cost-efficient radical prostatectomy with a clinical care path. 1996 Annual meeting of the American Urological Association, J Urol 1996;155:679A. 15. Dhanani N, Litwin MS: The effects of physician specialty on resource use and outcomes. Annual meeting of the Association for Health Services Research, Atlanta, GA, June, 1996. 16. Shpall AI, Litwin MS, Dorey F: Patient satisfaction after radical prostatectomy with a clinical care path. 1997 Western Student Medical Research Conference, American Federation for Clinical Research. 17. Litwin MS, Lubeck DP, Henning JM, Carroll PR: Differences in urologist and patient assessment of symptoms in prostate cancer: Results from the CaPSURE database. 1997 Annual meeting of the American Urological Association, J Urol 1997;157:426A. 18. Carroll PR, Lubeck D, Warolin KL, Henning JM, Litwin MS: Changes in health-related quality of life after diagnosis of prostate cancer: Results form the CaPSURE database. 1997 Annual meeting of the American Urological Association, J Urol 1997;157:233A. 19. Nied R, Penson DF, Dhanani N, Litwin MS: Effect of erectile dysfunction on health-related quality of life. 1997 Annual meeting of the American Urological Association, J Urol 1997;157:427A. 20. Litwin MS, Dhanani N: Differences in primary care physicians' and urologists' use of hospital resources in patients with UTI. 1997 Annual meeting of the American Urological Association, J Urol 1997;157:157A. 21. Shpall AI, Dorey F, Litwin MS: Health-related quality of life in men undergoing different treatments for advanced prostate cancer. 1997 Annual meeting of the American Urological Association, J Urol 1997;157:333A.
  18. 18. MARK S. LITWIN, MD, MPH Page 18 of 32 9/12/08 22. Grossfeld G, Stier D, Flanders S, Henning J, Litwin M, Carroll P: Patterns of failure following definitive treatment for prostate cancer: data from the CaPSURE database. 1997 Annual meeting of the AUA Western Section. 23. Lubeck DP, Litwin MS, Henning JM, Carroll PR: Measurement of health-related quality of life in prostate cancer: data from the CaPSURE database. 1997 Annual meeting of the American Public Health Association. 24. Litwin MS: Patient utilities for health states in men at risk for early prostate cancer. 1998 Innovators in Urology Symposium, London, UK, Prost Ca Prost Dis 1998; 1 (Suppl 1): S10. 25. Flanders S, Henning JM, Lubeck DP, Pasta DJ, Stoddard ML, Litwin MS: A multivariate analysis of sexual function and bother in men treated with prostatectomy or irradiation for early stage prostate cancer: Quality of life results from the CaPSURE database. 1998 Annual meeting of the American Urological Association, J Urol 1998;159:219A. 26. Lubeck DP, Bloor LE, Mathias SD, Carroll PR, Henning JM, Litwin MS: Validation of an instrument to measure patient satisfaction with health care in men with prostate cancer: Data from the CaPSURE database. 1998 Annual meeting of the American Urological Association, J Urol 1998;159:259A. 27. Saigal CS, Nease RF, Kaminski ALR, Litwin MS: Patient utilities for urinary, sexual, and bowel dysfunction in men at risk for prostate cancer. 1998 Annual meeting of the American Urological Association, J Urol 1998;159:259A. 28. Flanders S, Henning JM, Lubeck DP, Pasta DJ, Stoddard ML, Litwin MS: Changes in sexual function and bother in men treated for prostate cancer: Results from the CaPSURE database. 1998 Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research. 29. Traum AE, Wenger N, Litwin MS: Responding to a request for vasectomy from a young man without children. 1998 Annual meeting of the Society for General Internal Medicine. 30. Lubeck DP, Litwin MS, Henning JM, Stoddard ML, Flanders S, Carroll PR: Changes in health-related quality of life after treatment for prostate cancer. 1998 Annual meeting of the AUA Western Section. 31. Litwin MS, McNaughton-Collins M, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA, Alexander RB, Farrar JT, O’Leary MP: The NIH Chronic Prostatitis Symptom Index(NIH-CPSI): development and validation of a new outcomes measure. 1999 Annual meeting of the American Urological Association, J Urol 1999; 161: 31A. 32. Saigal CS, Brandeis JM, Reid K, Nease R, Litwin MS: Patient utilities for incontinence predict treatment choice in men with newly diagnosed prostate cancer. 1999 Annual meeting of the American Urological Association, J Urol 1999; 161: 36A. 33. Brandeis JM, Litwin MS, Burnison CM, Reiter RE: Early quality of life outcomes in men receiving brachytherapy or radical prostatectomy. 1999 Annual meeting of the American Urological Association, J Urol 1999; 161: 335A. 34. Lubeck DP, Stoddard ML, Flanders SC, Henning JM, Litwin MS: Utilization and costs of medical care for prostate cancer patients in the year prior to death: results from the CaPSURE database. 1999 Annual meeting of the American Urological Association, J Urol 1999; 161: 12A. 35. Shonfeld WH, Warolin KL, Henke CJ, Stier DM, Carroll PR, Flanders SC, Penson DF, Litwin MS: First year costs of treating prostate cancer diagnosed at different stages: results from the CaPSURE database. 1999 Annual meeting of the American Urological Association, J Urol 1999; 161: 332A. 36. Penson DF, Stoddard ML, Pasta D, Lubeck DP, Flanders SC, Litwin MS: Insurance status affects quality of life outcomes in men with prostate cancer: results from the CaPSURE database. 1999 Annual meeting of the American Urological Association, J Urol 1999; 161: 13A. 37. Lubeck DP, Litwin MS, Flanders SC, Henning JM, Carroll PR: Utilization of complementary and alternative medicine (CAM) treatments among prostate cancer patients in CaPSURE. 1999 Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research. 38. Lubeck DP, Stoddard M, Flanders SC, Henning JM: Differences in end-of-life medical care costs for prostate cancer patients: Results from CaPSURE database. 1999 Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research. 39. Lubeck, DP, Stoddard M, Flanders SC, Henning JM, Litwin MS. Differences in medical care costs for prostate cancer patients in the last year of life: Results from the CaPSURE database. 1999 Annual meeting of the Association for Health Services Research. 40. Flanders S, Pasta D, Stoddard M, Penson DF, Litwin MS. Predictors of Sildenafil failure in men being treated for prostate cancer: Data from CaPSURE. World Health Organization 2nd International Consultation on Prostate Cancer, 1999. 41. Litwin MS, Brandeis JM, Burnison, CM, Reiter RE: Quality of life outcomes after brachytherapy for early stage prostate cancer. 1999 Innovators in Urology Symposium, Keble College, University of Oxford, Oxford, UK, Prost Ca Prost Dis 1999 2 (Suppl 3): S19-S20 42. Lubeck DP, Litwin MS, Flanders SC, Henning JM, Carroll PR: The relationship between health-related quality of life and the use of complementary and alternative medicine among prostate cancer patients. 1999 Annual meeting of the International Society of Quality of Life Research. 43. Litwin MS: Sexual function and quality of life in men with prostate cancer. High Quality Patient Care Through Innovation in Medicine Symposium. Queens’ College, University of Cambridge, Cambridge, UK, 1999.
  19. 19. MARK S. LITWIN, MD, MPH Page 19 of 32 9/12/08 44. Lubeck DL, Litwin MS, Flanders SC, Henning JM, Carroll PR: The relationship between health-related quality of life and the use of complementary and alternative medicine among prostate cancer patients. International Society for Quality of Life Research, 1999. 45. Litwin MS, Reid K, Brandeis JM, Saigal CS. Quality of life impairment in men of color presenting for prostate cancer evaluation. 2000 Annual meeting of the American Urological Association. 46. Brandeis JM, Chand I, Kwan L, Dougherty S, Reiter RE, Litwin MS. A prospective study of the short term effects of radical prostatectomy vs. brachytherapy on quality of life. 2000 Annual meeting of the American Urological Association. 47. Brandeis JM, Pashos C, Henning JM, Litwin MS. A nationwide cost comparison of the principal treatments for early stage prostate cancer. 2000 Annual meeting of the American Urological Association. 48. Brandeis JM, Chand I, Kwan L, Dougherty S, Reiter RE, Litwin MS. Pre-treatment quality of life in men with early stage prostate cancer. 2000 Annual meeting of the American Urological Association. 49. Flanders SC, Pasta DJ, Stoddard ML, Penson DF, Litwin MS. Predictors of Sildenafil failure in men being treated for prostate cancer. 2000 Annual meeting of the American Urological Association. 50. Lubeck DL, Litwin MS, Li YP, Flanders SC, Carroll PR. Quality of life after metastatic prostate cancer: results from the CaPSURE database. 2000 Annual meeting of the American Urological Association. 51. McNaughton-Collins M, O’Leary MP, Litwin MS, Calhoun EA, Kusek JW, Santanna S, Landis JR. Quality of life is impaired in men with chronic prostatitis: results from the NIH cohort study. 2000 Annual meeting of the American Urological Association. 52. Brandeis J, Pashos CL, Henning JM, Litwin MS. Racial differences in the cost of treating men with early stage prostate cancer. 2000 Annual meeting of the International Society for Pharmacoeconomics and Outcomes Research. 53. Burkhardt JH, Hayman JA, Litwin MS, Rose CM, Correa RJ, Sunshine JH, Hogan, C. Comparing the Costs of Different Treatments for Prostate Cancer. 2000 Annual meeting of the American Society for Therapeutic Radiology and Oncology. 54. Litwin MS: A prospective, longitudinal study of the short-term effects of brachytherapy vs. radical prostatectomy on health-related quality of life. Prost Ca Prost Dis 2000; 3 (Suppl 1): S26. 55. O’Leary MP. McNaughton-Collins M, Santanna J, Propert KJ, Litwin MS. Are there long term changes in symptoms over time in men with chronic prostatitis? An interim report from the Chronic Prostatitis Cohort. 2001 Annual meeting of the American Urological Association.. 56. Calhoun EA, McNaughton-Collins M, O’Leary MP, Pontari MA, Santanna J, Landis JR, Litwin MS. What is the economic impact of chronic prostatitis? 2001 Annual meeting of the American Urological Association. 57. Saigal CS, Reid K, Gornbein J, Litwin MS. Stability of utilities for health states associated with the treatment of prostate cancer. 2001 Annual meeting of the American Urological Association. 58. Freedland SJ, Blanco-Yarosh M, Litwin MS, Rajfer J, Sun JC, Hale SJ, Smith RB, Elashoff DE, Gritsch HA. Improved Open Donor Nephrectomy Using A Clinical Care Pathway and Ketorolac for Post-Operative Pain. 2001 Annual meeting of the American Urological Association. 59. Korfage IJ, Essink-Bot M, Madalinska JB, Kirkels WJ, Litwin MS, de Koning HJ. Translation and development of a Dutch prostate cancer quality of life questionnaire. 2001 Meeting of the International Society for Quality of Life Research. 60. Litwin MS, O'Leary MP, Adler A, Calhoun EA, Pontari MA, Eremenco SL, Chang CH, Odom L, McNaughton Collins M. The Spanish NIH-Chronic Prostatitis Symptom Index: Translation and Linguistic Validation. 2001 Meeting of the International Society for Quality of Life Research. 61. Chang C-H, Cella D, Bennett C L, Litwin MS. Quality of life item banking and computerized adaptive testing in prostate cancer. Proceedings of the 9th SPORE Investigators’ Workshop, July 2001. 62. Cormier L, Reid K, Litwin MS. Particularites du depistage du cancer de la prostate dans les familles a risque. Resultats preliminaires. Presented at the 2001 annual meeting of the Association Francais d’Urologie. 63. Cormier L, Reid K, Wkan L, Litwin MS. Prostate cancer knowledge in brothers and sons. 2002 Annual meeting of the European Association of Urology. 64. Litwin MS, Brandeis J, Chand I, Kwan L, Dougherty S, Reiter RE. Quality of life in the year following brachytherapy, External beam radiation, or prostatectomy. 2002 Annual meeting of the American Urological Association. 65. Miller DC, Montie JE, Resh J, Dunn RL, Litwin MS, Wei JT. Feasibility and sensitivity of the RAND candidate quality of care indicators for localized prostate cancer care. 2002 Annual meeting of the American Urological Association. 66. Pontari MA, Litwin MS, O’Leary MP, McNaughton-Collins M, Calhoun E, Knauss J, Landis JR. A case-control study of epidemiological factors in men with chronic pelvic pain syndrome. 2002 Annual meeting of the American Urological Association. 67. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Surgeon volume predicts radical prostatectomy outcomes. 2002 Annual meeting of the American Urological Association.
  20. 20. MARK S. LITWIN, MD, MPH Page 20 of 32 9/12/08 68. Spencer BA, Steinberg M, McGlynn EA, Brumberger E, Litwin MS. Quality of care indicators for radical prostatectomy. 2003 Annual meeting of the American Urological Association. 69. Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR, Litwin MS. Predicting quality of life after radical prostatectomy: results from CaPSURE. 2003 Annual meeting of the American Urological Association. 70. Krupski TL, Saigal CS, Litwin MS. Variation in continence and potency by definition. 2003 Annual meeting of the American Urological Association. 71. Mehta SS, Lubeck DP, Pasta DJ, Litwin MS. Fear of cancer recurrence in prostate cancer patients undergoing definitive treatment: Results from CaPSURE. 2003 Annual meeting of International Society for Pharmacoeconomics and Outcomes Research. 72. Spencer BA, Steinberg M, McGlynn EA, Brumberger E, Litwin MS. Quality of care indicators for conventional and conformal external-beam radiation therapy in the treatment of early stage prostate cancer. 2003 Annual meeting of the American Society for Therapeutic Radiology and Oncology. 73. Yano E, Wang M, Saigal C, Litwin MS. Urologic disease burden in the US: veteran users of VA health care. 2003 Annual meeting of Academy Health Society. 74. Botteman MF, Pashos CL, Litwin MS. Economic comparison of two uroselective alpha-blockers as first line drug therapy for the management of moderate-to-severe benign prostatic hyperplasia. 2003 Annual meeting of the AUA New York Section. 75. Krupski TL, Smith MR, Lee WC, Pashos CL, Brandman J, Wang Q, Botteman M, Litwin MS. Adverse bone effects in men with prostate cancer on androgen deprivation therapy. 4th International Conference on Cancer-Induced Bone Diseases, 2003. 76. Litwin MS, Lubeck DP, Elkin EP, Broering JM, Greenfield S, Kaplan SH. Validation of an instrument to measure comorbitity in men with prostate cancer: Results from CaPSURE. 2004 Annual meeting of the American Urological Association. 77. Maliski SL, Kwan L, Krupski TL, Fink A, Litwin MS. Low-income prostate cancer patients have poor self-efficacy for communicating with their physicians. 2004 Annual meeting of the American Urological Association. 78. Saigal CS, Joyce G, Pace J, Litwin MS. The economic costs of urolithiasis in the private sector. 2004 Annual meeting of the American Urological Association. 79. Krupski TL, Kwan L, Litwin MS. Geographic variation in treatment for African American and white men with prostate cancer. 2004 Annual meeting of the American Urological Association. 80. Krupski TL, Smith MR, Lee WC, Pashos CL, Brandman J, Wang Q, Botteman M, Litwin MS. Fracture risk in men with prostate cancer on androgen deprivation therapy. 2004 Annual meeting of the American Urological Association. 81. Krupski TL, Tanouye C, Fink A, Kwan L, Connor S, Litwin MS. Health related quality of life in low-income, uninsured men with prostate cancer. 2004 Annual meeting of the American Urological Association. 82. Alexander RB, Propert KJ, Schaeffer AJ, Landis R, Kusek JW, Litwin MS. A randomized trial of ciprofloxacin and tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome. 2004 Annual meeting of the American Urological Association. 83. Connor SE, Maliski SL, Fink A, Litwin, M. Desired and acquired by prostate cancer patients: ethnic specific focus group analysis. 9th Biennial Symposium on Minorities and the Medically Underserved and Cancer, Washington, DC, 2004. 84. Maliski SL, Kwan T, Krupski T, Fink A, Litwin, M. Low-income prostate cancer patients have poor self-efficacy for communicating with their physicians. 9th Biennial Symposium on Minorities and the Medically Underserved and Cancer, Washington, DC, 2004. 85. Krupski TL, Smith MR, Lee WC, Pashos CL, Brandman J, Wang Q, Botteman M, Litwin MS. Profile of men with prostate cancer on androgen deprivation therapy at greatest risk of bone complications. 2004 Annual meeting of the American Society of Clinical Oncology. 86. Connor SE, Kohl L, Tatum A, Joost S, Robles S, Agonia C, Litwin MS. Getting the word out: Lessons learned from a statewide campaign to promote a free prostate cancer treatment program. 2004 Annual meeting of the American Public Health Association. 87. Maliski SL, Walling A, Weintraub D, Bogorad A, Litwin MS. Evaluation of readily available prostate cancer patient education materials. 2004 Annual meeting of the American Public Health Association. 88. Maliski SL, Clerkin B, Litwin MS. Describing nurse case manager strategies to empower low-income prostate cancer patients. 2004 Annual meeting of the American Public Health Association. 89. Connor SE, Maliski SL, Fink A, Litwin MS. Information desired and acquired by prostate cancer patients: Ethnic specific focus group analysis. 2004 Annual meeting of the American Public Health Association. 90. Maliski SL, Kwan L, Orecklin JR, Saigal CS, Litwin MS. Pretreatment predictors of post prostate cancer treatment fatigue. 2004 National Conference on Cancer Nursing Research.
  21. 21. MARK S. LITWIN, MD, MPH Page 21 of 32 9/12/08 91. Maliski SL, Litwin MS. Unsolicited comments on quantitative surveys: an untapped data source. 2004 National Conference on Cancer Nursing Research. 92. Maliski SL, Litwin MS. The meaning of prostate cancer treatment-related erectile dysfunction in low-income Latino men. 2004 National Conference on Cancer Nursing Research. 93. Hu JC, Elkin E, Litwin MS. The effect of post-prostatectomy external beam radiotherapy on quality of life: Results from CaPSURE. 2005 Annual meeting of the American Urological Association. 94. Saigal CS, Gore J, Polich S, Litwin MS. Trends in reconstruction after radical cystectomy in the Medicare population. 2005 Annual meeting of the American Urological Association. 95. Gore J, Saigal CS, Litwin MS. Marriage and mortality in bladder cancer. 2005 Annual meeting of the American Urological Association. 96. Anger JT, Saigal CS, Litwin MS. The prevalence of urinary incontinence among community-dwelling adults: Results from the National Health and Nutrition Examination Survey (NHANES). 2005 Annual meeting of the American Urological Association. 97. Anger JT, Saigal CS, Litwin MS. Treatment of urinary incontinence: Increasing expenditures for female Medicare beneficiaries. 2005 Annual meeting of the American Urological Association. 98. Spencer BA, Babey S, Etzioni D, Ponce N, Brown ER, Litwin MS. A population-based survey of PSA testing among California men at higher risk for prostate cancer. 2005 Annual meeting of the American Urological Association. 99. Spencer BA, McGlynn E, Steinberg M, Adams J, Setodji S, Litwin MS. Quality-of-care indicators for early-stage prostate cancer. 2005 Annual meeting of the American Urological Association. 100. O'Leary M, Litwin MS, Manyak M, Miner M, Penson D, Roehrborn C. Correlation of International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index and SF-12 in a Practice Setting. 2005 Annual meeting of the American Urological Association. 101. Krupski TL, Saigal C, Hanley J, Litwin MS. Patterns of care for men with prostate cancer on androgen deprivation therapy 2005 Winter meeting of the Society for Urologic Oncology. 102. Spencer BA, Miller DC, Ritchey J, Stewart A, Litwin MS, Wei JT. Prostate cancer quality of care: The American College of Surgeons Special Study. 2006 Annual meeting of the American Society for Clinical Oncology. 103. Litwin MS, Greenfield S, Elkin EP, Lubeck D, Broering JM, Kaplan SH. Mortality is predicted by a comorbidity measure in men with prostate cancer: results from CaPSURE. 2006 Annual meeting of the American Urological Association. 104. Krupski TL, Foley KA, Baser O, Long S, Macarios D, Litwin MS. Health care cost associated with prostate cancer, androgen deprivation therapy, and bone complications. 2006 Annual meeting of the American Urological Association. 105. Krupski TL, Foley KA, Baser O, Long S, Macarios D, Litwin MS. Androgen deprivation therapy increased fracture risk in men with prostate cancer. 2006 Annual meeting of the American Urological Association. 106. Krupski TA, Saigal C, Hanley J, Schonlau M, Litwin MS. Patterns of care for men with prostate cancer following failure of primary treatment. 2006 Annual meeting of the American Urological Association. 107. Hu JC, Wood D, Andriole G, Dunn RL, Dahl D, Hollenbeck BK, Kibel A, Saigal CS, Litwin MS, Pisters L, Klein E, Montie JE, Wei JT, Sanda MG. Perioperative quality care indicators of retropubic, laparoscopic, and robotic prostatectomy: results from a national, multi-center, prospective cohort. 2006 Annual meeting of the American Urological Association. 108. Sanda MG, Dunn RL, Northouse L, Litwin MS, Hembroff L, Sandler HM, Michalski J, Klein EA, Mahadevan A, Kibel A, Saigal CS, Pisters L, Kuban D, Kaplan I, Wei JT.Prostate cancer physician performance measured by patient-reported ratings of practitioner manner/skill and by treatment-related adverse events. 2006 Annual meeting of the American Urological Association. 109. Penson DF, Litwin MS, Payne R, Te AE, Metzger C, Wei JT. Do Socioeconomic Characteristics Play a Role in Treatment Choice for BPH? 2006 Annual meeting of the American Urological Association. 110. Anger JT, Litwin MS, Wang Q, Chen E, Pashos CL, Rodriguez LV. Racial disparities in the surgical management of stress incontinence among female medicare beneficiaries. 2006 Annual meeting of the American Urological Association. 111. Anger JT, Rodriguez LV, Wang Q, Pashos CL, Litwin MS. High-volume providers perform more prolapse repairs at the time of sling surgery. 2006 Annual meeting of the American Urological Association. 112. Anger JT, Litwin MS, Wang Q, Pashos CL, Rodriguez LV. Complications of sling surgery among female medicare beneficiaries. 2006 Annual meeting of the American Urological Association. 113. Anger JT, Litwin MS, Wang Q, Pashos CL, Rodriguez LV. Variations in stress incontinence and prolapse management by surgeon specialty. 2006 Annual meeting of the American Urological Association.

×